🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to explore the safety and feasibility of anti-...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2023-10-31
Trial ID
NCT06109207
Treatments Being Tested
This study is a multicenter, prospective, randomized, open-label clinical s...
Status
Recruiting
Location
Fujian Cancer Hosptial
Start Date
2026-01-21
Trial ID
NCT07581834
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
The purpose of this study is to explore the safety and feasibility of anti-...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2023-12-29
Trial ID
NCT06225921
Treatments Being Tested
This is a single-center, single-arm phase Ib / II clinical trial, which was...
Status
Unknown
Location
Cancer Center of Sun-Yat Sen University (CCSYSU)
Start Date
2023-07-01
Trial ID
NCT05952128
Treatments Being Tested
While immune-based therapies (including targeted-immune or dual-immune regi...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-11-05
Trial ID
NCT07238881
This study aims to evaluate the safety, tolerability, PK and preliminary an...
Status
Unknown
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT05792410
The investigator conduct a phase II multi-center, open-label trial to evalu...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2023-11-17
Trial ID
NCT06341894
Treatments Being Tested
This single-center, open-label Phase II trial aims to evaluate the efficacy...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07778732
Treatments Being Tested